Effects of Whey and Collagen on FFM, Muscle Strength and Wound Healing in Elderly Surgical Patients
The Effects of Whey Protein and Collagen on Fat Free Mass, Muscle Strength and Wound Healing in Elderly Patients Undergoing Elective Knee- or Hip Surgery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hellerup
-
Gentofte, Hellerup, Denmark, 2900
- Herlev/Gentofte Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 65+ years
- Scheduled elective knee- or hip surgery
- Must be able to understand and speak danish
- Must be able to chew and swallow food with a regular consistency
- Must be able to consume the assigned protein supplementation
- Must be able to consent participation
Exclusion Criteria:
- Vegan
- Demensia
- Critical complications to the surgery which prevents the patient from participating in the rehabilitation program
- Plasma-creatinin above 250 micromol/L
- Palliative patients
- Known intolerance of whey protein and/or collagen
- Patients with a pacemaker
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Collagen
Participants of this arm are going to consume 30 g of collagen peptides daily for 30 days
|
Participants of each arm will consume 30 g daily of the assigned protein supplementation for 30 days.
The protein supplementation will be given as protein powder which the participants will have to dissolve in cold drinks.
During the intervention fat free mass, muscle strength, functional ability, wound healing and life quality of the participants will be monitored.
|
|
EXPERIMENTAL: Whey Protein
Participants of this arm are going to consume 30 g of whey protein daily for 30 days
|
Participants of each arm will consume 30 g daily of the assigned protein supplementation for 30 days.
The protein supplementation will be given as protein powder which the participants will have to dissolve in cold drinks.
During the intervention fat free mass, muscle strength, functional ability, wound healing and life quality of the participants will be monitored.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The difference in fat free mass
Time Frame: Weekly for 30 days
|
The outcome will be monitored through BIA and the development of fat free mass in the operated leg will be compared to the development of fat free mass in the non-operated leg.
|
Weekly for 30 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound healing
Time Frame: Weekly for 30 days
|
The amount of days until the wound is healed (defined as: the epithelium is covered without crust).
This will be monitored trough pictures and assessed on a scale from 1-5 by a masked doctor.
|
Weekly for 30 days
|
|
Redness and infection
Time Frame: Weekly for 30 days
|
The redness and infection around the wound assessed on a scale from 1-5 by a masked doctor through pictures.
|
Weekly for 30 days
|
|
Handgrip strength
Time Frame: Weekly for 30 days
|
Handgrip strength measured by a handdynanometer (SAEHAN) in kg and percentage
|
Weekly for 30 days
|
|
Extension strength of quadriceps femoris
Time Frame: Weekly for 30 days
|
Measured in amounts of repetitions of 0.5 or 1.0 kg.
|
Weekly for 30 days
|
|
Life quality
Time Frame: Weekly for 30 days
|
Measured trough EuroQol-5D-5L
|
Weekly for 30 days
|
|
Difference in functional ability (NMS)
Time Frame: Weekly 30 days
|
Assessed by New mobility score
|
Weekly 30 days
|
|
Difference in Chair stand test
Time Frame: Weekly for 30 days
|
Measured by amount of repetitions
|
Weekly for 30 days
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Palatability of the protein supplementation
Time Frame: 30 days
|
Assessed on a scale from 1-5
|
30 days
|
|
Consistency of the protein supplementation
Time Frame: 30 days
|
Assessed on a scale from 1-5
|
30 days
|
|
Compliance of the protein supplementation intake
Time Frame: Weekly for 30 days
|
Assessed trough a weekly form, which the participants will fill in
|
Weekly for 30 days
|
|
Rapported side effects
Time Frame: 30 days
|
Participants will be informed to rapport if they experience any side effects throughout the intervention
|
30 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ValleKollagen
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.